Intermediate-conductance calcium-activated potassium channel, KCa3.1, plays an important role in macrophage migration in atherosclerosis

被引：0
|
作者：
Miura, Hiroto
Toyama, Kazuyoshi
Fujiwara, Yoshimasa
Saito, Takashi
Hatoum, Ossama
Gutterman, David
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Mem Hosp, Katagami, Japan
[3] Gen Hosp, Akita, Japan
[4] Israel Inst Technol, Haifa, Israel
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2007年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E71 / E71
页数：1
相关论文
共 50 条
  • [41] Involvement of the calcium-activated potassium channel (KCA3.1) in apoptotic neurodegeneration and neuroinflammation induced by ethanol in neonatal mice
    Saito, M.
    Subbanna, S.
    Zhang, X.
    Nandwana, N. K.
    Smiley, J. F.
    Wilson, D. A.
    Das, B. C.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 179 - 179
  • [42] The Intermediate-conductance Ca2+ -activated K+ Channel KCa3.1 Regulates Monocyte Adhesiveness to VCAM-1 and Macrophage Cholesterol Efflux
    Lemaitre, Vincent
    Filimban, Linda
    Miura, Hiroto
    CIRCULATION, 2012, 126 (21)
  • [43] A human intermediate conductance calcium-activated potassium channel
    Ishii, TM
    Silvia, C
    Hirschberg, B
    Bond, CT
    Adelman, JP
    Maylie, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11651 - 11656
  • [44] Intermediate-conductance Ca2+-activated K+ channel, KCa3.1 as a novel therapeutic target for benign prostatic hyperplasia
    Niwa, Satomi
    Ohya, Susumu
    Kojima, Yoshiyuki
    Sasaki, Shoichi
    Sakuragi, Motomu
    Kohri, Kenjiro
    Imaizumi, Yuji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 94P - 94P
  • [45] Intermediate-Conductance Ca2+-Activated K+ Channel, KCa3.1, as a Novel Therapeutic Target for Benign Prostatic Hyperplasia
    Ohya, Susumu
    Niwa, Satomi
    Kojima, Yoshiyuki
    Sasaki, Shoichi
    Sakuragi, Motomu
    Kohri, Kenjiro
    Imaizumi, Yuji
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (02): : 528 - 536
  • [46] Role of the potassium channel KCa3.1 in diabetic nephropathy
    Huang, Chunling
    Pollock, Carol A.
    Chen, Xin-Ming
    CLINICAL SCIENCE, 2014, 127 (7-8) : 423 - 433
  • [47] The distribution of intermediate-conductance, calcium-activated, potassium (IK) channels in epithelial cells
    Thompson-Vest, N
    Shimizu, Y
    Hunne, B
    Furness, JB
    JOURNAL OF ANATOMY, 2006, 208 (02) : 219 - 229
  • [48] Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain
    P. Pedarzani
    M. Stocker
    Cellular and Molecular Life Sciences, 2008, 65 : 3196 - 3217
  • [49] Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain
    Pedarzani, P.
    Stocker, M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (20) : 3196 - 3217
  • [50] The role of the intermediate conductance calcium-activated potassium channel IK in breast cancer
    Mohr, C. J.
    Steudel, F. A.
    Lo, W. Y.
    Stegen, B.
    Huber, S. M.
    Hoppe, R.
    Schroth, W.
    Brauch, H.
    Ruth, P.
    Lukowski, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S64 - S65
12345